Coromandel International Limited (NSE:COROMANDEL) Q2 FY23 Earnings Concall dated Nov. 04, 2022
Corporate Participants:
Ankur Periwal — Senior Vice President
Sameer Goel — Managing Director
Jayashree Satagopan — Chief Financial Officer
Analysts:
Tarang Agrawal — Oldbridge Capital — Analyst
Himanshu Binani — APLNG — Analyst
Manish Mahawar — Antique Stock Broking — Analyst
Bharat Sheth — Quest Investment Advisors — Analyst
Ranjit — IF Securities — Analyst
Rohan Gupta — Nuvama — Analyst
Abhijit Akella — Sumikapital — Analyst
Krishan Bari — Elara Capital — Analyst
Presentation:
Operator
Ladies and gentlemen, good day, and welcome to the Coromandel International Limited Q2 FY ’23 Results Conference Call hosted by Axis Capital Limited. [Operator Instructions]
I will now hand the conference over to Ankur Periwal from Axis Capital. Thank you, and over to you, sir.
Ankur Periwal — Senior Vice President
Yes. Thank you, Katy. Good evening, friends, and welcome to Coromandel International Limited Q2 FY ’23 Post Results Earnings Call. The call, as usual, will be initiated with a brief management discussion on Q2 and H1 performance followed by an interactive Q&A session. Management team will be represented by Mr. Sameer Goel, Managing Director; Mr. Jayashree Satagopan, Chief Financial Officer; and Mr. Mayur Gangwal, GM Finance.
Over to you, Samir, sir, for the initial remarks.
Sameer Goel — Managing Director
Good afternoon, everyone, and thanks, Ankur organizing the conference call. I’m audible, Ankur?
Ankur Periwal — Senior Vice President
Yes, sir, you are.
Sameer Goel — Managing Director
Right. So just to start off, global economy, the global economy is to slow down from 6% in 2021 to 3.2% in 2022 to 2.7% in 2023. It is facing several challenges, inflation higher than witnessed in several decades, tightening financial conditions in most regions and resulting calibration of monetary policies. I think the main issue is the strengthening of the dollar against major currencies and the Russian-Ukraine war all going heavily on the global economy, future help. A bit positive news on the agriculture side, food price index has declined to 136.3% in September of 2022, sharply lower than the record high of 159.7% in March. The main reason is that please some exports are a time out of main agriculture market, Ukraine.
Also, the commodity prices, which were hired globally has been softening. Coming to Indian economy, most of you would know Indian economy is progressing better through the growth rates, which — though the growth rates have been revised downwards and India is likely to remain the fastest-growing large economy in the world. The tax collections have been buoyant. reflecting all ground performance of the economy. The headwinds are rupee depreciation, high inflation and of course, energy prices will need to be watched. The good news is the Indian agriculture continues to be obliged for India received the fourth consecutive year of good monsoon. South and monsoon was 106% of the loan term averages. South and Central part of India where we operate received excess rainfall. While not was a regular but got educate as to had a huge deficit.
The crop acreage is free for that INR110 lakh hectares down prior to the previous year. We are also cotton has done better. But obviously, there is a deficit in Padi, mainly as a result of the less acreage, which happened in the Eastern part and UP part. The Northeast monsoon is expected to be normal. And with good reservoir levels currently of 108% of last year. We do expect the Rabi season to be good. Coming to the fertilizer industrial performance. The global supply of key commodities improved during the quarter, and the industry has witnessed softening trends for major raw materials. The only place where we expect some earnings to happen in ammonia, a lot will depend upon how the winters are there in Europe. Domestically, the fertilizer demand has remained strong, supported by good monsoons and favorable policies by the government.
Coming to the quarter, DAP and complex industry timely sales volume was up by 11%. Currently about 64.6 lakh metric tons while last year, it was 58.5 lakh metric tons and mainly as a result of higher import of the eight. And confidence quick flavor. sales, which are actual consumption went up by 6%. Currently was 6.7 — 67.2 lakh metric tons versus 63.6 lakh metric tonne last year. As I mentioned before, major raw material prices witnessed a downward trend against all 10. The NBS rate for Rabi for the full year ’22, ’23 has been approved by the pandemic. Subsidy for Rabi season will be the tune of INR51.875 crores. For year-to-date, DAT and complex fertilizer industry primary sales volume were up by 15% Current year was 11.91 lakh metric tons vis-a-vis 103.4 lakh metric tonnes last year.
DAP and complex fertilizer industry cost sales, which is consumption sales was marginally down by 1%. Current year was 103.7 lakh metric ton versus 104.3 lakh metric tons previous year. Coming now to Coromandel performance. Like you have seen, Coromandel delivered a robust performance during the quarter, registering strong growth in turnover and profitability with the agricultural environment remaining favorable in most of its key operating markets. Normal crop sowing coupled by favorable policies from the Health. Coromandel registered a revenue growth of 65% during the quarter and 62% for which was largely led by higher subsidies and MRP in the Nutritional business. Other businesses did well lean volumes. Coromandel ensures that inputs are made available to the farmers in its key operating markets and promoted the use of balance mutation, including organic fertilizer to help bridge eliminate 3rd by farm productivity.
Specifically on the Coromandel Nutritional segment performance, the Nutritional and Allied business, which includes our specialty nutrition and organic revenue increased by 73% during the quarter and 70% during the half year. Company specialized nutrition and organic products registered a very good growth, both in terms of turnover and profitability. We now introduced in the liquid fertilizer segment, which is the first in the Indian market and economists calcium during the quarter. On the sales front, in quarter 2, BAP complete volume was at 12.4 lakh tonnes, 11% higher than last year at 11.2 lakh metric tons. For YTD, DAP complex volume was at 19.7 lakh metric tons versus 19 lakh metric tons last year. Manufactured DAP and complex volume was higher by 19% during the quarter and 6% during the half year of last year. Imported products was lower by 30% during the quarter and down by 14% during half year of last year.
Company market share in quarter two was 19.2% and half year was 16.5%. Last year, it was the same for quarter two at 19.2% and 18.4% for half year. In the complex segment, market share for quarter two was 28.8%. Last year was 26.6% and H1 was 28.4% versus 26.3% against last year. This is on the sales. SSP quarter two sales was 2.43 lakh metric tons with a growth of 8% over last year. And for the half year, it was at four lakh metric tons. Market share for the half year was at 14.3%, which was down from 16.1% last year. Maybe on our first half quarter 1. Our commercial team have been oppressed with the latest development in the global market and has ensured timely availability of raw material to ensure continuous production at the manufacturing plant. During the quarter, our DAP and complex plans operated at 107% capacity and at 99% during the half year and produced 9.2 lakh metric tons of fertilizer during the quarter and 17.16 metric tons during the half year.
For fluoric acid production during the quarter was again at an all-time high of 1.2 lakh tonnes and H1 was 2.3 lakh metric tons. Progress on our key capex or as per plan, the work on sulfuric acid project is progressing well and will be commissioned as per schedule. We have initiated a desalination plant at our [Indecipherable] plant, which will help to improve our operational flexibility going forward. To further enhance SSC facilities, the company is increasing the granulation facility. A new facility has come up at a plant in and, which was added to this value. We have also revised poly hospice plant and also we are manufacturing in our Qatari plant. Progress by our technology team on new products working like Nano wefit customized fertilizers as for our internal plan. With these initiatives, we will continue to promote balanced nutrition approach and support the farming communities.
In fact, we have successfully done grown trials with our specialized and liquid fertilizer in the market, and they have been well expected by the farmers. Turning to Crop Protection. Crop Protection business registered a growth of 1% in revenue for the quarter and 3% for the year. Increase in key raw material costs and price challenges due to high production of Mancozeb impacted domestic business to business and its core business. Domestic formulation witnessed a very good growth with positive traction from the new product launches, which we have made this year. And in a single year, we have exceeded our full year target. The business has received a total of five patents during this year. These are unique product combinations which has been developed by our own R&D team and this will argue well for our crop protection business as we come.
The business is building a rich product pipeline backed by strong R&D capabilities and is partnering with global investors to further strengthen its product offering. On the manufacturing side, the PPP that operated at a capacity utilization of 53% in quarter two. Last year was 77% and 56% during the half year last year was 78%. The main reason for this was we had to slow down our production on 9% due to the stocks that we had. However, this has not picked up with the softening of from cable vessel. The alkylation plant has had a very high capacity utilization, and we are expanding the capacity. Work has set up on a new multi-plant for the manufacture of [Indecipherable], which has been publishing them and is expected to be commissioned during the year. As I mentioned for nutrition, we have successfully done spring trials in the farm field in crop protection also.
The business will go be scaling up usage of bonding the remaining part of the year. Our retail centers operated very well during the quarter, focusing on providing all grown agri solutions, including products from advisory and Realization. service. Business has improved its operational efficiency and leverage technology to read out the performance. In quarter 2, which has a record 94% of our sold have been profitable and retail has operated with negative working caps. As part of our digital transformation journey, Coromandel has strengthened its digital data center initiatives, which includes creating unified data platform on cloud helping automatic cash bonds and building advanced use cases for the business. It is also created enough data for our manufacturing center.
The company has taken significant steps in the last one year in the adoption of tunes intelligent bases] Sales force productivity tools and robotic automation has improved the process efficiency. With the expectations of normal northeast monsoon and higher reservoir levels, Indian agriculture would be a bright spot. With the strength of a key operating markets for Coromandel will continue. To ensure time the availability of agri input in the farming it through our dealers and our retail outlets. Coromandel diversified presence across the and we’ll continue to provide balance recreation and integrated at mania solution to maximize farm productivity.
I’d now like to hand over to Jayashree the company’s financial.
Jayashree Satagopan — Chief Financial Officer
Thank you, Sameer, and good afternoon all. I will now provide updates on the company financials. In terms of turnover, the company recorded a consolidated total income of INR1,145 crores during this quarter and INR15,927 crores in the first half. The numbers for the corresponding period last year is INR6,166 crores for quarter two and INR982 crores for the first half. The company has registered a growth of 65% during the quarter and 62% during the half year. The increase in revenue has been mainly on account of higher subsidy and MRP realizations in the fertilizer business, driven by high RM costs and allied businesses contributed to 92% share and the remaining 7% coming from crop protection business in the quarter. And for the half year, it is 91% and 9%, respectively.
Company norms of the share of business stands at 89% and 11% during the quarter and 87% and 13% during the half year. During the previous year, it was 83% and 17% during the quarter and ’18 and ’20 during the half year. As far as the profitability is concerned, the consolidated EBITDA for the quarter was INR1,058 crores as against INR744 crores last year. And for the first half, it was INR1,644 crores as against INR1,129 crores last year. In terms of the breakup between subsidy and nonsubsidy business, it’s 78% at 22% during the quarter and sales for the first half. During the previous year, it was 71% and 29% for the quarter and 22% and 28% for the first half. Net profit after tax for the quarter was INR741 crores in comparison to INR519 crores for the corresponding quarter last year and INR140 crores for the half year against INR1,857 crores last year.
On the subsidy front, here in the quarter, the company received INR3,866 crores. Comparative figure last year was for the half year, Database INR4,002 crores and the previous year, we grow [Indecipherable] months Subsidy outstanding as INR4,176 crores vis-a-vis INR1,698 crores during the previous year. On the interest front, during the quarter, company incurred a net interest expense, excluding Indias Interest of INR13 crores vis-a-vis interest income of INR38 crores in the same quarter last year. For the half year, company earned a net interest income of INR eight crores versus INR20 crore interest income in the previous year. Company maintained a surplus fund of almost INR2,324 crores in bold accrued securities And, these have been earmarked for specific capex and growth-related investments.
Short-term borrowings of INR1,279 crores were taken to bridge the higher working capital requirement. Our company’s balance sheet continues to be strong. During the proper, the company received AAA stable rating by India Ratings and Research of each group company and a short term we reading at A1+. Company’s long-term credit rating by Crizal continue to be increasing AA+ postage and the short-term rating at Brazil. During Q2, rupee was extremely volatile and traded in a very broad range of Coromandel followed a prudent considerate approach of regime before its exposure, thereby limiting the impact of currency depreciation.
We thank for your interest in Coromandel joining us in the con call today. We shall open the session for question and answer.
Questions and Answers:
Operator
[Operator Instructions] The first question is from the line of Tarang Agrawal from Oldbridge Capital. Please go-ahead.
Tarang Agrawal — Oldbridge Capital — Analyst
Hello good evening and congratulations for, an extremely strong set of numbers. I have a couple of questions. One, on the manufacturing of your phosphatics and manufacturing of SSP. As we go forward, can we expect you to probably cross your prosthetics manufacturing volumes north of three million tonnes and SSP volumes north of 7.5 million tonnes. Considering the capacity constraints or the debottleneckings that you might have. So that’s number one. Number two, if you could give us some trend on how prices have moved for you in the past? And what was the price for the upcoming period?
Jayashree Satagopan — Chief Financial Officer
So thank you for all four questions. As regards the capacity for manufacturing of NPKs and SSP. The question was whether we would exceed the three million tonnes and 7.5 lakh tons of capacity that we have, definitely, with the debottlenecking that has happened and the use of different furthers of raw material. We believe that both these are possible. As far as the PA price trend is concerned, we have seen the prices shooting up from last July onwards, July ’21 onwards, we’ve seen an uptick. Last quarter, for instance, the PA prices was almost $1,715 per metric ton. The current quarter, it is $1,175 per metric ton. So after a continuous increase in the prices, we are seeing the raw material prices are cooling down, and we expect this trend to continue.
Tarang Agrawal — Oldbridge Capital — Analyst
Okay, thank you.
Operator
Thank you. The next question is from the line of — sorry, the next question is from the line of Himanshu Binani from APLNG. That is probably other India Please go-ahead.
Himanshu Binani — APLNG — Analyst
Thank you for taking my questions. And congratulations on a good set of numbers. So I have two questions. Number one is on the margin side. So despite we are seeing a lower contribution of the units.
Operator
This is the operator, Mr. Binani, can you speak a little closer to the phone, we unable to hear you?
Himanshu Binani — APLNG — Analyst
Is that audible?.
Operator
Yes.
Himanshu Binani — APLNG — Analyst
Sir, despite the same lower contribution of unit grades to the overall volumes, while the increased volumes in the trading side of the business. And what I understand is that some of the competitors have actually posted the numbers citing taking some inventory loss from the carryover inventory from the last year also. And due to the volatility into the RM prices from 2Q, 3Q, so there might be some component of inventory loss also in that. But despite that, we have like posted this sort of EBITDA per ton in the manufactured volumes.
So just wanted to have a sense on how the margin profile are and how should one actually look into the EBITDA numbers going forward? And the second question was on the capex side. So sir, any sense or color on the capacity enhancement into the complex fertilizer side, I think we are like we have just alluded that we are already working at optimum utilization. So going forward, is there any plans for enhanced capacities into the complex fertilizer site?
Sameer Goel — Managing Director
So just was you talked about the margins. Obviously, when we look at how we do our planning, we look at whichever grades are giving us good return depending on the raw material and the contagion cost and the market as per the crop demand, we go for that. So that is how we’ve done how we look at things. That’s one part of it. And the good thing about Coromandel is we have a lot of grades to choose from, and we can promote the many various.
You said more trading volume, we did not do no traded volumes as far as NPK is concerned, I have actually highlighted that we have done less given the higher raw material given the higher prices, which had happened. But at the same time, we did manufacture some of them fertilizer, which we do more. And that’s why we enhance our manufactured fertilizer. One of the good thing was we were able to source all of our materials on time. And therefore, our manufacturing team are able to manufacture and the still alluded in the discussion, we also to improve our efficiencies — we want to answer the capacity.
Jayashree Satagopan — Chief Financial Officer
The other thing, Himanshu, that we need to also look into is the integration that has been undertaken, which has been a tremendous help in terms of the value capture at our end, right? Now I will talk about the capex. The capex plan for the year was close to even to INR900 crores. We are tracking well on it. The projects are going well. Currently, in the plan, we were from debottlenecking capex but at the same time, depending on the market conditions, we are also exploring what could be the future capacity creation. For instance, we have set up a liquid fertilizer plant, and that is currently getting fully operational. We are also looking into setting up in the coming year possibly another liquid fertilizer plant, which could be used for, nano for which we are currently going through the regulatory approval processes. So there is a word that’s going on in the businesses to look at capacity augmentation and future capacity creation.
Himanshu Binani — APLNG — Analyst
Right. And was there any sort of inventory loss component, which is into the reported numbers?
Jayashree Satagopan — Chief Financial Officer
I think you’re referring to the cumber comment.
Himanshu Binani — APLNG — Analyst
Right. Right.
Jayashree Satagopan — Chief Financial Officer
Yes. So as we do not be so much in DAC, we don’t have any inventory-related loss. The way the government has set up the subsidy for DAP Wolf, anything that is manufactured during the year INR3,000 of subsidy and anything which is in the carryforward inventory of prior year was about INR30,000 of inventory. In the last quarter, on the carryforward inventory, we had recognized only INR33,000 and therefore, there is nothing to come and impact to remind these books this year.
Operator
Thank you. The next question is from the line of Manish Mahawar from Antique Stock Broking Please go-ahead.
Manish Mahawar — Antique Stock Broking — Analyst
Yeah good evening everyone first question is in terms of NBS rate, where the government has announced a day before your study. So how do you see the rates and action in terms of MRP in the marketplace? And how do you see the — for the full year subsidiary outlook for government as a whole and a payment to the companies?
Jayashree Satagopan — Chief Financial Officer
In the way it has been announced by the government is well close to what has been announced for the current session. And the raw material prices have been coming down. So at an appropriate time, we believe that the government will be relooking into the MDS race and may come with a downward correction. Having said that, when the raw material prices come down and the subsidy at its current level, there is also a response medical companies to see how we work through the and those options are being contemplated by Coromandel as well.
Manish Mahawar — Antique Stock Broking — Analyst
Okay. But currently, what the government has announced the rate and for asset price, right, how much maybe possibly do you think MRP will be come down in this next three months, maybe the government will take time to reevaluate this number further?
Jayashree Satagopan — Chief Financial Officer
That is being worked out, Manish. So possibly, we will get a clarity on it in the next one or two weeks. And accordingly, the actions will be taken in the market. As regards to question was how is the game disclosing there is an additional outlook which has been approved by the cabinet and even in the month of October, we have received more close to INR2,500 crores of subsidy from them. And we hope during the next couple of months also, they should be in a position to process and paring subsidy outstanding to the companies.
Sameer Goel — Managing Director
The comment has been very good at this.
Manish Mahawar — Antique Stock Broking — Analyst
Okay. So by March, maybe ’23, do you think the situation will the balance sheet as well as the subsidy outstanding has increased, right, in terms of — because of a debt number if we normalized by March ’23, benefit time?
Jayashree Satagopan — Chief Financial Officer
I think so and seeing that the government has paid out the money almost all through the year. This time also, they have taken approval from the cabinet. And I do not see a reason why not get paid.
Manish Mahawar — Antique Stock Broking — Analyst
Okay, understood. And second question, in terms of production capacity, which the earlier question also asked about what type of — because right now, what — how much of a production we can do because you have done a lot of debottlenecking NPK plant, what is the optimal production we can do in the existing capacities? In terms of NPK I’m talking about or debt?
Sameer Goel — Managing Director
We can continue to do even more production. A lot also depends on how we take our annual turnaround did depend on a number of factors, which includes the demand in the market, but more importantly, when you look at the safety of our plants and equipment. So that is something which we will take a call closer to the time, and it is a non season.
Manish Mahawar — Antique Stock Broking — Analyst
Okay. But any number you can say but could you maybe 35%, what type of number we can manufacture on an annual basis?
Jayashree Satagopan — Chief Financial Officer
I think we should be able to do between 32 to 33 lakh tonnes as Sameer mentioned, there are two factors that could come in. One is the mix that we adopt. There are going to be certain products the throughput is going to be much higher. And if you’re going to do too many products and we do a changeover that is going to impact. There are certain products with the throttle lower. So one is the component of mix. The second one is the timing of the ATA, right? During an annual turnaround normally between 15 to 30, 35 days the plant could be shut down, depending whether it is a fully integrated plant or a recessive granulation plant.
And therefore, these also come and impact us to that piece. So [Indecipherable], between INR32 crores to INR33 Lakhs if possible. But if you have to take a call, say, I want to do an ADA in March vis-a-vis April, then there would be a lower production. So that call normally, the manufacturing team takes about a couple of times before. That’s a flow of looking to the amount of incapacity.
Manish Mahawar — Antique Stock Broking — Analyst
Okay. And last one in this same question. In terms of granulation plant, right, maybe the filter expansion, how much time do you think we will maybe or we are waiting for, again, raw mat sourcing for basically the final plant?
Jayashree Satagopan — Chief Financial Officer
Yes. We have mentioned in the previous call that it is going to be important for us to showing as we look into for the capacity expansion. So the business is looking into seeing how we can get our PAS secure. How we think about additional valuation capacity.
Manish Mahawar — Antique Stock Broking — Analyst
But anyways, once you set up a plant, right, it will take around 18 to 24 months’ time to come on stream, right, in the plant?
Jayashree Satagopan — Chief Financial Officer
Definitely.
Manish Mahawar — Antique Stock Broking — Analyst
Okay okay sure sir from my side thanks and all the best.
Operator
Thank you. The next question is from the line of Bharat Sheth from Quest Investment Advisors. Please go-ahead.
Bharat Sheth — Quest Investment Advisors — Analyst
Hi thanks for the of what Sameer sorry. Coming on this crop protection, despite, I mean, we have been introducing new and we have been taking on earlier old product moving out this time, also our growth is not I mean, compared to industry is very low. So where do we see a sustainable growth? And what are the factors that has affected the growth.
Sameer Goel — Managing Director
So firstly, our domestic growth has been very close. We have — when we compare across the companies. Our domestic growth in corporate has been very good. This is despite the fact that we had what is called excessive range, and therefore, it stopped some of the, what is called application to happen during the quarter because of excessive rates. And like we said, we are obviously concentrating on our high margins and new products and therefore, we have also done downsizing of some of the other products where the margins have been an issue, but this requires investments.
So domestically, things have been well. There has been pressure like we mentioned in our call on which is has had added capacity plus also across both in the export and the domestic market, primarily also got to do with the high prices, which were in what we could do and that has impacted some of the things. The thing is raw material prices also coming down. And we are putting up the thing. And therefore, again, from September onwards, we are seeing quite a good up. Is, you want to add anything?
Jayashree Satagopan — Chief Financial Officer
Yes. Sameer said, the prime reason for the unit sales is our exports and B2B markets, mostly driven by [Indecipherable]. That is also because of the high RM costs. And the decision from a business was not a pile more in at a much lower cost. Having said that, in the last month or so, the raw material prices have eased and therefore, it gives an opportunity for additional that is sales during the coming quarter. On the domestic front, we had a most on the formulation business. We had almost a 29% growth year-on-year and the new projects that have got introduced has been doing extremely well, which is also held in sort of balancing the margins overall. As far as PTC is concerned, there are two, three things which going forward should help the business. One, the new multipurpose plant that is being constructed at [Indecipherable] should be ready for commissioning in January to the coming year.
This will be manufacturing through three technical Azoxy, Pioski and Supreme. This should complement and also help produce a heavy dependence on [Indecipherable]. Apart from this, the business is looking into further new technical which have become offtake in the last few years. We’ve identified in the first list in other 10 AI, out of which the R&D team has come out with the DoD for six of them. So the business is looking at a new proposal for setting up multicopper plant. And the proposal should hopefully come in and get clear in the next two to three months’ time. All these actions in terms of cruising up the AI portfolio will help in the B2B business, which is both export and domestic. On the formulation front, the business is continuing to look at the introduction of new molecules.
This year, ALDI has been introduced, one more in the pipeline for the coming quarter. And the business has also got taken for five combination molecules. Which also for the first time. Apart from this, about 23-odd registrations have been successfully obtained for the global market, which also includes some combination-related registrations. While the current quarter has been soft, we think some of the actions that have been taken up should help get a much better portfolio mix for crop protection and also address some of the concerns on the overdependence of manage. Apart — also looking into deeper penetration in select Southeast Asian market to go on an aggressive B2B and also possibly on.
Bharat Sheth — Quest Investment Advisors — Analyst
Sir, currently, Mancozeb contribute how much to the total revenue? And second question related, this five new patent we got it so have we already launched the product? Or when are we — if not then, when we will be seeing those product launching?
Jayashree Satagopan — Chief Financial Officer
Okay. Good question. Mancozeb currently is about 45 percentage of total revenue. It used to be 60%, 65%. It has come down to some extent, but full export is heavily dependent on Mancozeb. As far as the size newly patented molecule, the patent of the receipts. So we will be working on the formulation, and we should see the product launches in the coming year.
Bharat Sheth — Quest Investment Advisors — Analyst
So in Rabi season, do we expect or it will be again next year only?
Jayashree Satagopan — Chief Financial Officer
This will be next year. In early season, we will be coming up with another net product for launch.
Bharat Sheth — Quest Investment Advisors — Analyst
And how much are these specialty nutrient and organic is contributing? And what — if you can give roughly around the size of that business? And how do we see the prospect of that?
Jayashree Satagopan — Chief Financial Officer
Yes. Specialty nutrients and organic as the business has been growing quite well. We have seen the business growing in almost 25, 30 percentage on a year-on-year and currently, on a year-to-date basis, there will be about INR25-odd crores in terms of revenue.
Bharat Sheth — Quest Investment Advisors — Analyst
Fair. And on the SSP side, any color I would like to give? Or how is the profitability vis-a-vis which was earlier with now new granulation facility coming up.
Jayashree Satagopan — Chief Financial Officer
Sorry, can you repeat the question, please?
Sameer Goel — Managing Director
Business is doing quite well. One of the issues which we had was to increase our capacity which we have done by revising, we had — like we have told, we had now ball a couple of plants, which we review are also taking some additional facility from [Indecipherable] and we are expanding the graduation facility. The gradation facility not only helps to improve the use of SSP, but also helps in terms of launching our new products like, which is now doing extremely well and has a better margin profile.
One good thing which we should have mentioned is, which is happening from the government is on toxicity on-trade Now this will help us to supply almost pan India, especially the big markets on the East where currently we are not tapping so that are supplying regularly. So we will be doing that also. So SST, we continue to see it grow. Even the government is promoting SST against the imported DAP, especially in the markets of North and West as a better substitute because from a farmer’s point of view, it not only gets for [Indecipherable], but also gives other required mining, which is very useful for this one.
Operator
Sir, you’re done with your questions.
Sameer Goel — Managing Director
Yes. I think two questions are return.
Operator
So we move to the next question, which is from the line of Ranjit [Phonetic] from IF Securities.
Ranjit — IF Securities — Analyst
Yeah hi sir thank you for taking my question. My question is on the profitability of the fertilizer segment. We have been out forcing our guidance for quite some time now. So whether there are any thoughts of the EBITDA per tonne guidance revising upwards. And the second question is that we have also seen a bit of hardening in the prices of the ROC phosphate. I do believe that we have been having the super efficiencies and probably part of that, at least on the ROC phosphate front, do we see adeno prices might lead to a bit of pressure on the conversion or the benefits that we have been getting due to the backward integration.
Jayashree Satagopan — Chief Financial Officer
Thanks, [Indecipherable] your question. On the profitability front, we had you guided on EBITDA per tonne of about 400 or the three years. Given the way the margins have turned out to the first half. I think it would be reasonable to expect the margins will be better during the somewhere between INR5,500 per metric ton or something which I think could be feasible. On the row for [Indecipherable] pricing that you were mentioning, which we note that the prices across the commodities, etc., ammonia has been partnering and we are seeing a similar trend in block protein. So I don’t see a reason why the prices for first pay would go up. DAP prices are down for pecan prices are down, we are seeing softening the profit as well.
Ranjit — IF Securities — Analyst
Would we be able to — the guidance is for this year or even for the next year? Do we see a fair bit of comfort?
Jayashree Satagopan — Chief Financial Officer
I think the guidance is for this year, as we work out the business plan we should be in a question to guide for the coming year.
Ranjit — IF Securities — Analyst
Sure ma’am thank you.
Operator
Thank you. The next question is from the line of Rohan Gupta from Nuvama. Please go-ahead.
Rohan Gupta — Nuvama — Analyst
Yeah hi sir good evening and thanks for the opportunity and congratulation on such a strong set of numbers in the current quarter. Sir, two to three questions from my side. So first, we start with on just the current phosphate prices, what are the contractual prices for [Indecipherable] though that government may look at further reducing the prices or the subsidy, but I think that the subsidy rate which has been announced so far are already fixed for the entire baby season. And if the market prices are remaining or hold on to the farmers or the current level, do you see that the margins that currently with in DAP and NPK fertilizer will be much better than what we have already seen in first half?
Jayashree Satagopan — Chief Financial Officer
Yes, Rohan. The forecast prices, as I mentioned, for this quarter is about it and it has come down from $1,716 in the last quarter. So as I was mentioning, while the cabinet has gone through the MBS rate, and we have the force which paise for the ready season. And there is going to be set reduction in the prices. We believe the government may look into the NDA rate and could come with a deficient during even with the disease, but we’ll have to wait and watch. Second, as we further the prices have got finalized for the quarter and the raw material prices are coming down. The company has also been having inventory for continued production.
So there is going to be some level of high cost inventory, which has to get liquidated. And to that extent, that will also sort of compensate for the margin. The third one, as I was mentioning, that we wind with earning prices coming down. There is also responsibilities for companies to look into how some of the delisted passed on to the powers who are end consumers. So that is being worked out and probably in the next couple of weeks as we go through the cost proposals should be coming up on MRP related actions.
Rohan Gupta — Nuvama — Analyst
Ma’am, can you quantify or some numbers a little bit at high cost inventory, which we have on the raw material, what can the impact on profitability. And I think that all will be visible in Q3?
Jayashree Satagopan — Chief Financial Officer
Yes, mostly all this should come into Q3. And this varies, right, across various raw materials. We could be farm on the first crisis. We have some drops, which are being put which are for a longer term. And then there is also a certain quantum of sulfuric so we’ve seen the prices in all these commodities coming down. So it is a mix between various raw materials. And I’m hoping that most of it should get exhausted in the coming quarters in the current quarter.
Rohan Gupta — Nuvama — Analyst
But in respect to the high-cost inventory, if I look at closely the — as you also mentioned that the government reduction in subsidiary is on DAP is hardly INR1,500 per ton. And if we maintain the prices to the farmers at the same day, it means that even the previous raw material, which we are carrying is enough to maintain our old margins. However, now the fast asset which we are procuring right now is going to have a significant improvement in margins. So I didn’t get that will the inventory losses, which we’re talking about can be anything significant because the subsidy has not come down sharply and the pharma prices will remain the same.
Jayashree Satagopan — Chief Financial Officer
I don’t see a significant reduction in the margin segment. However, having said that, this is also the value gap that is captured and the water bid prices are very high, right? Because when you do your own backward integration, you do manufacturing of forecasting, there is a value capture that happens between you’re buying the block on commenting into action, we are buying assets. And the asset price has come down. It’s good in a way, but at the same time, the value capture in terms of getting the rock and processing will also come down. amount.
That is the reason why I am saying and correction that could be possible. And you know that we are not mostly into DAP, we are into NPP, and there are different grades of Panel. So when you look into a combination of all of these factors, and think that he could sort of some extent moderate the margin compared to what we have seen in Q2. Overall in the year is, I think we’ll still be better than last year.
Rohan Gupta — Nuvama — Analyst
Second, in terms of the margin guidance which you gave as we have already seen a first half solid number. So definitely at INR5,500 EBITDA per ton may not only hold on when we may exceed that number as well that what looks like. For next year, any sense that do you see that these are the sustainable margins which one should be looking at going forward even at the process it coming down and the backward integration, which we have now. So do you see that these are the sustainable margin pertain related?
Jayashree Satagopan — Chief Financial Officer
I think so over the years, we have seen that the margins per se have been getting better with a lot of efficiencies that are being built in the plant and the plant operating at a higher capacity and the dewatering making efforts are also helping to spread the fixed costs better. Margins should be definitely in the range of 5,500 like more. I think those are good numbers for us to look into.
Sameer Goel — Managing Director
Like Jayashree, we’ll go through the planning process, and we’ll be able to tell you that for the next year.
Rohan Gupta — Nuvama — Analyst
Fine enough. Sir, on our agrochemicals part of the business, we have been highlighting that we are open for growth, and it will also have been very aggressively looking for inorganic growth opportunities also in that segment and even in other businesses as well related to Agri. Do you see that we are having enough options and we are getting such opportunities, which you may like to pursue and we may see some inorganic growth opportunities as well in the agrochemicals part of the business or in terms of you want to build the business towards the contract manufacturing and the intermediate manufacturing or grams model, we would like to increase significantly in the agrochemical part of the business over the next couple of years. How do you see that business panning out?
Sameer Goel — Managing Director
So we have had a detailed listing with McKenzie, which is a long-term strategy. And we look — we are looking at each of the news which we have talked about right? And this is not therefore crop protection, but we’ll also look for any other age businesses, which are there, but it needs to make business sense to us. So that is something which we have done. We’ve already seen that our [Indecipherable] has invested very well in three startups, including we have taken up a grown company manufacturing we’ve taken share there and part of the deepens so that we can then leverage them for our own operations for the benefit for the farmer, which is both for the crop protection and the mutations about these. So we’ll continue to look for the opportunity.
Rohan Gupta — Nuvama — Analyst
Thank you guys.
Operator
Thank you. [Operator Instructions] We move to the next question from the line of Abhijit Akella from Sumikapital. Please go-ahead
Abhijit Akella — Sumikapital — Analyst
Yes thank you. So congrats, the opportunity. I have a couple of questions. The first one is that what kind of a sustainable benefit that we can get in our EBITDA per tonne on account of the recent phosphate acid expansion that we’ve done as well as the new sulfuric acid and first backward integration that we’re going to complete in next year and in the next two years as well. So what kind of a benefit that we get in EBITDA per tonne because of that?
Jayashree Satagopan — Chief Financial Officer
So the benefits of PAs already been factored in and as far as that will get commissioned next year, I had indicated earlier, this is more to do with securing our raw material. So that we can avoid a high fluctuation in the procurement price. There will be benefits in terms of our team that gets generated, so on and so forth. The primary intent of putting up a separate plan to ensure that our imports are coming down, and we are not subject to huge volatility. So I think can help with some improvement to help us with our negotiating power. That’s the way one should look into the capacity that you’re getting on a.
Abhijit Akella — Sumikapital — Analyst
Under the normalized environment, I know the primary reason is raw material security, but you also — you also have some kind of an arbitrage in pricing even if do raw material prices in an large environment are not elevated as they have been in the past. So there must be some kind of a quantifiable benefit that you would have received on account of just putting up the facility.
Jayashree Satagopan — Chief Financial Officer
There could be some, which I said normally, this comes from the forward looking.
Abhijit Akella — Sumikapital — Analyst
Can you quantify that?
Jayashree Satagopan — Chief Financial Officer
I don’t have the number right at me Ashar. Probably, we can take it offline, you can give us a call, and I’ll have the number of it.
Abhijit Akella — Sumikapital — Analyst
Okay. And my second question is on anode. As you said that it is still in the approval process what kind of — what kind of margins and what kind of growth are we seeing in anode and the application of land pending the fertilizer industry. And as you know, your competitor already has a patent, which he has taken three months back from ADP. So how will that create a threat to our something in terms of the NAND that we are going to release.
Jayashree Satagopan — Chief Financial Officer
I think there are a couple of companies who have applied for approval for. So each one will be following a different process. And once we get all the approvals, then the manufacturing distribution will start. We have done the trial in the file. And we find that the results are quite encouraging. Normally, these are emitted tons and therefore, it is a full year application. We’ll have to see to what extent is we sort of substitute the granulated DAP. But our estimate is that it could be anywhere around 15%, 20%. Over a long period in time. Initially, the adoption could be lower and over a period in time based on the input that comes from the field relating the intravasation because these are very, very early stages of these new products that are being introduced.
Abhijit Akella — Sumikapital — Analyst
Ma’am, I assume that there will be the nanotech you guys have been testing and will you position.
Jayashree Satagopan — Chief Financial Officer
We can’t hear you.
Abhijit Akella — Sumikapital — Analyst
Am I audible now?
Jayashree Satagopan — Chief Financial Officer
Yes.
Abhijit Akella — Sumikapital — Analyst
So my question was that the Nano GP that you are testing and has been given for the approval process, will that be of a different grade than your competitors are using?
Jayashree Satagopan — Chief Financial Officer
Nobody else today, who has come with nano DAP. There is been manufacturers and distributed by so.
Abhijit Akella — Sumikapital — Analyst
But has already achieved, of course, already been granted a patent for an annual DAP three months back.
Sameer Goel — Managing Director
What you are trying to say is the processes are different entirely different, so there is no issue.
Abhijit Akella — Sumikapital — Analyst
Yeah. Okay. Okay thank you
Operator
Thank you. The next question is from the line of Krishan Bari from Elara Capital. Please go head.
Krishan Bari — Elara Capital — Analyst
Yeah thanks for the opportunity. Ma’am, while you have quantified that the high-cost inventory would be exhausted in Q3. But specifically at the start of Q3 or during the start of Q3, how much of rock high-cost inventory will be there for how many days, if you can quantify in terms of number of days?
Jayashree Satagopan — Chief Financial Officer
I don’t have those numbers right away with Kishan. Typically, pace could be for 20 to 30 days, right? It also depends upon the mix that we are using. And rough could be for a slightly longer period. because we don’t know how the forest prices are going to be within or predicted of prices. They typically rock you hold because we’ve not been efficient to import. That’s been a normal case, when the material prices are going up. Sensing that there should be some moderation in the prices as we went through August and September. We have consciously been to and sort of months and reduced the inventory for rock, which typically is for a longer period. So the inventory that we are holding are not at the same level that one used to hold when the raw material prices are going up. It is lower. While it is lower since the prices are coming down, you will definitely see some impact.
Krishan Bari — Elara Capital — Analyst
And ma’am, would the strategy be to reduce the MRP after we liquidate the high-cost inventory?
Jayashree Satagopan — Chief Financial Officer
I think that’s what we have been looking at. I don’t have an answer. We look at after liquidation of high cost inventory or it could be like then on an average, we will be able to achieve a certain cost proposal position. And therefore, is it better to part on the benefit to the farmers. So that’s something that is being considered by the management.
Krishan Bari — Elara Capital — Analyst
Sure. And I’m just a bit on a longer horizon with the kind of initiatives that we are taking on crop protection, organic and specialty nutrient. Do you think that the incremental growth from these three segments will be able to give us a decent incremental growth maybe next year or FY ’25 onwards, so that we don’t feel the impact of lower volume growth in the core complex fertilizer business.
Jayashree Satagopan — Chief Financial Officer
Kishan, the way we are looking into each of the SBUs it will have your own growth path and credit team. There is opportunities across all the business. Obviously, CPC or SME and organic have several white space opportunities as — for instance, in CT, we can look at the Indian market, we can look into global market, both for B2B and B2C There are opportunities to look into product or contract manufacturing. On SMB, more of liquid fertilizers coming with the variants that could impact. There is a much more opportunity out there. Organic, again, is a very, very sought-after product. And we are seeing as well as revenue during the year. So these will have their own aggressive growth plan. At the same time, there is opportunity for the fertilizer business that will also have a strong growth.
For instance, between last year to this year, the ASP growth has been very good. Oil is much lower in terms of cost compared to NPK, given the high prices that happened to a good uptake of SSP. And even in SSP, we are looking into converting most of the powder into granulation. There is value-added that we are looking into. So each of our businesses are looking into how they can plan, how they can grow and grow profitability in profitably in each of the areas. So that focus will continue. And Sameer mentioned earlier, apart from the existing will be trying to grow. There are going to be focus areas in terms of how we even use technology to aid the farmers in improving the productivity.
We have been in the last year or so, investing into asset companies, we do three investment profile. All of them are very promising, primarily the drone investment that we have done in as in the last quarter. We think it’s going to be very strategic for amendments. Because we deliver cost going up, more of liquid applications coming in, whether it is in crop protection, specialty nutrients the usage has grown is going to be hurting the farmers in terms of getting the better efficacy as well as reducing the cost of input labor. So we want be exploring multiple opportunities across the existing businesses and adjacencies to enable consistent growth within coming.
Krishan Bari — Elara Capital — Analyst
Sure. And lastly, for the Nano fertilizers or organic or specialty nutrients, how many seasons or years of demand generation is required at the farmer end? And we have been trying to do this since then?
Sameer Goel — Managing Director
So what we did was for our specialty businesses and organic, we already got the agronomic team set up. which is basically an export market, which works with the farmers. And they work on specific crop types obviously, it is a concept selling. But now the farm works and including the fact that we can ease them with digital media, are adopting this very fast. So we do see a very fast adoption. In fact, our strategy here is to move more away from taking more into manufacturing so that we can also do the value capture and at the same time, upgrade our offering to the farmers.
For example, in sulfur, we used to sell go the pioneers and myself but now we have moved to a much more better product for the farmers called [Indecipherable]. We also have BOSS marketed. So we have limited our sales of winter in sulfur, which has become general so we keep doing this to ensure that adoption is very fast, and I believe that our agronomic aided with the net clinics, which we have in the key markets, Coromandel is very much on our retail outlook, we are very much geared up for a very fast in production.
Krishan Bari — Elara Capital — Analyst
Thank you. That’s it from my side.
Operator
Thank you. Ladies and gentlemen, this was the last question for today. I now hand the conference over to the management for their closing comments. Over to you, sir.
Sameer Goel — Managing Director
Yes. Thank you very much. Thanks for taking your time on a Friday evening. But it’s been a very interesting and challenging year last six months, especially given the international crisis, which is the especially with the [Indecipherable]. But I think your company with what we have done in the past and with our diversified portfolio, and our direct contacts with the farmers, both through retail outlets and within the clinic has done very well with the storm, which is there, which is impacting across the industry and have been able to deliver.
I think given our farmers focus and the new products which are in the minus application plus advent into AdTech and you have seen reality there. It’s no longer just a dream. We will continue to support the farmers in key markets for improving the productivity. And then the company will continue to do well. So thank you very much.
Operator
[Operator Closing Remarks]